S&P 500 Consumer Staples Sector SEC Filings — January 08, 2026

09-01-2026

Ellington Financial Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001437, Size: 215 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial impacts, or quantitative metrics are disclosed in the provided filing summary. All numerical values, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

09-01-2026

Welsbach Technology Metals Acquisition Corp. filed an 8-K on 2026-01-09 (AccNo: 0001213900-26-002600, Size: 5 MB) disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of financial obligations (Item 2.03), unregistered equity sales (Item 3.02), modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), governance amendments (Item 5.03), and code of ethics amendments (Item 5.05). This indicates a significant merger/acquisition event likely involving a SPAC de-SPAC transaction, but target identity, deal terms, valuation, and financial details are NOT_DISCLOSED. Sector is not specified.

09-01-2026

Haemonetics Corp filed a Form 8-K on January 09, 2026 (AccNo: 0000313143-26-000003, Size: 723 KB) reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financials, or exhibits are disclosed in the provided filing summary. This is a multi-item filing from the US SEC with sector not specified.

09-01-2026

Brookfield Asset Management Ltd. filed a Form 8-K on January 09, 2026 (AccNo: 0001171843-26-000153, Size: 224 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial impacts, or exhibits are disclosed in the filing summary. Sector not specified.

09-01-2026

Prelude Therapeutics Inc filed a Form 8-K on January 09, 2026 (AccNo: 0001193125-26-008280, Size: 14 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Intellia Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008307, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial impacts, or quantitative data are explicitly stated in the provided filing summary. This is a multi-item voluntary or mandatory disclosure depending on the underlying events, but core event details are NOT_DISCLOSED.

09-01-2026

Koppers Holdings Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001315257-26-000004, Size: 342 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or quantitative data provided in the summary; sector not specified.

09-01-2026

Ellington Credit Co filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001461, Size: 147 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with all core event details NOT_DISCLOSED.

09-01-2026

Aclarion, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001683168-26-000168, size 682 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of a core material event involving an unspecified agreement. No transaction details, financial metrics, or dollar values are disclosed.

09-01-2026

MAGELLAN COPPER & GOLD Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001683168-26-000181, size: 203 KB), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No details on the nature of the accountant change, disagreements, or financial exhibits are disclosed in the provided summary. This is a multi-item mandatory filing triggered by a material event.

09-01-2026

Kopin Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001064, size 199 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions, reasons, or terms are provided. Sector not specified.

09-01-2026

Proficient Auto Logistics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002912, Size: 215 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction, financials, or exhibits are disclosed in the provided filing summary. Sector not specified.

09-01-2026

ACTELIS NETWORKS INC filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002925, Size: 219 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with no further details on the events or exhibits provided. Sector not specified; all transaction, financial, and event specifics are NOT_DISCLOSED.

09-01-2026

Portsmouth Square Inc filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001107, Size: 201 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including key position affected, appointment/resignation status, reasons, or individuals involved are NOT_DISCLOSED.

09-01-2026

KKR Real Estate Finance Trust Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001140361-26-000843, Size: 199 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.

09-01-2026

Oracle Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009002, Size: 130 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment or resignation status, reasons, or other impacts are provided in the available information. Sector is not specified.

09-01-2026

Monte Rosa Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009005, size 677 KB), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No details on the core event, transaction value, parties involved, financial impacts, or strategic importance are disclosed in the provided information. This is a multi-item filing with no quantitative data available.

09-01-2026

KKR & Co. Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001140361-26-000841, Size: 214 KB), under Item 5.02 covering departures, elections, appointments of directors/officers, or compensatory arrangements. Specific details on the officer involved, position, appointment/resignation status, reasons, or impacts are NOT_DISCLOSED. Sector is not specified.

09-01-2026

BRAINSTORM CELL THERAPEUTICS INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002494, Size: 1 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific details on the agreement, transaction values, share counts, or other quantitative data provided in the summary. Sector is not specified.

09-01-2026

Aptera Motors Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001121, Size: 16 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction, financials, or other specifics are provided in the filing summary.

09-01-2026

Lakeland Industries Inc. filed a Form 8-K on 2026-01-09 (AccNo: 0001193125-26-008983, Size: 144 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.

09-01-2026

Momentus Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001140361-26-000853, Size: 1 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, transaction size, or equity sales provided in the summary. Sector not specified.

09-01-2026

FLYEXCLUSIVE INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009100, Size: 986 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. Sector is not specified.